CMTM6 expression in M2 macrophages is a potential predictor of PD-1/PD-L1 inhibitor response in colorectal cancer
2021 · Cancer Immunology Immunotherapy · 34 citations
https://doi.org/10.1007/s00262-021-02931-6
W
Wanming Hu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
112
Papers
1.5K
Citations
22
h-index
45
i10-index
Wanming Hu is an academic researcher from Sun Yat-sen University. The author has contributed to research in topics: Glioma Diagnosis and Treatment & Cancer Immunotherapy and Biomarkers & Radiomics and Machine Learning in Medical Imaging. The author has an h-index of 22, co-authored 96 publications.
ORCID: 0000-0002-3632-1258Papers by this author
worksDevelopment and validation of an RNA sequencing panel for gene fusions in soft tissue sarcoma
2022 · Cancer Science · 15 citations
https://doi.org/10.1111/cas.15317
A multicenter proof-of-concept study on deep learning-based intraoperative discrimination of primary central nervous system lymphoma
2024 · Nature Communications · 14 citations
https://doi.org/10.1038/s41467-024-48171-x
Establishment of Human Pituitary Neuroendocrine Tumor Derived Organoid and Its Pilot Application for Drug Screening
2024 · The Journal of Clinical Endocrinology & Metabolism · 8 citations
https://doi.org/10.1210/clinem/dgae228
Single-cell atlas profiling revealed cellular characteristics and dynamic changes after PD-1 blockade therapy of brain metastases from laryngeal squamous cell carcinoma
2024 · Molecular and Cellular Biochemistry · 4 citations
https://doi.org/10.1007/s11010-024-05064-3
m6A regulator-based molecular classification and hub genes associated with immune infiltration characteristics and clinical outcomes in diffuse gliomas
2025 · BMC Medical Genomics · 3 citations
https://doi.org/10.1186/s12920-025-02104-9
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat